Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Wong
University of California Los Angeles, Department: Dentistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
EZLifeBio
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Wong is the Principal Investigator for the study and the Scientific Adviser for the company.
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
Relevance to Public Health Statement Therapeutics are actively being developed to target mutations in cancer genes (druggable mutations), improving morbidity and/or mortality of patients. Liquid biopsy is the rapidly emerging field to access druggable mutations minimally/non-invasively in bodily fluids. This UH2/UH3 application is to advance a matured academic assay EFIRM-Liquid Biopsy (eLB), the best performance liquid biopsy technology that can detect with near perfect accuracy of actionable EGFR mutations in lung cancer patients, to a CLIA-certified laboratory developed test (eLB-LDT) to provide rapid, non-invasive and most accurate detection of treatable mutations in lung cancer, prolonging disease progression free survival period.
Filed on July 10, 2017.
Tell us what you know about David Wong's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David Wong filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | $100,000 - $149,999 |
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | $100,000 - $149,999 |
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | $100,000 - $149,999 |
| David Wong | University of California Los Angeles | Conflict of Interest | EZLifeBio | $40,000 - $59,999 |
| David Wong | University of California Los Angeles | Conflict of Interest | EZLifeBio | Value cannot be readily determined |
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | Value cannot be readily determined |
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | Value cannot be readily determined |
| David Wong | University of California Los Angeles | Conflict of Interest | RNAmeTRIX | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.